Classic case of fib level retracements
Target 1: $140
Target 2: $150
Target 3: $160
There are resistance levels to break between the targets.
RSI and MACD suggest there's energy to break towards target #3 prior to earnings.
Considering PEG, future outlook, product pipeline, news storyline and environment - MRNA has a good potential for 2021.
Earnings call will be critical milestone.
Target 1: $140
Target 2: $150
Target 3: $160
There are resistance levels to break between the targets.
RSI and MACD suggest there's energy to break towards target #3 prior to earnings.
Considering PEG, future outlook, product pipeline, news storyline and environment - MRNA has a good potential for 2021.
Earnings call will be critical milestone.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.